AstraZeneca and COVISHIELD vaccines: Risk of thrombosis with thrombocytopenia
In plain language
This recall involves the AstraZeneca COVID-19 Vaccine and COVISHIELD sold in Canada. It's being recalled because of a very rare risk of thrombosis with thrombocytopenia. Stop using the product and follow the return/repair steps in the official notice.
What to do
- Stop using the product immediately.
- Seek immediate medical attention if you develop symptoms such as shortness of breath, chest pain, leg swelling, or persistent abdominal pain after vaccination.
- Seek prompt medical attention for neurological symptoms like severe headaches or blurred vision, or skin bruising/petechiae several days after vaccination.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
AstraZeneca COVID-19 Vaccine
Model: DIN: 02510847, DIN: 02511444
COVISHIELD
Model: DIN: 02512947
Why this matters
Risk of thrombosis with thrombocytopenia
Do I have this product?
This recall only applies to specific products. Follow the steps below to check.
- 1
Check the product name
Make sure your product name matches one of the affected products listed above.
- 2
Check the model number
Model numbers are typically on the product label or packaging.
Affected models: DIN: 02510847, DIN: 02511444, DIN: 02512947
If your product matches one or more of the details above, it may be affected by this recall.
If your product does not match these details, it is not affected by this recall.
When in doubt, always check the official notice.
Frequently Asked Questions
Why was this product recalled?
Risk of thrombosis with thrombocytopenia
What should consumers do?
Stop using the product immediately. Seek immediate medical attention if you develop symptoms such as shortness of breath, chest pain, leg swelling, or persistent abdominal pain after vaccination. Seek prompt medical attention for neurological symptoms like severe headaches or blurred vision, or skin bruising/petechiae several days after vaccination.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. Risk of thrombosis with thrombocytopenia
When was this product recalled?
This product was recalled on March 24, 2021.
Is the AstraZeneca, COVISHIELD brand affected by this recall?
Yes, AstraZeneca, COVISHIELD products are affected by this recall. This recall involves the AstraZeneca COVID-19 Vaccine and COVISHIELD sold in Canada. It's being recalled because of a very rare risk of thrombosis with thrombocytopenia. Stop using the product and follow the return/repair steps in the official notice.